Strides Pharma receives USFDA approval for Celecoxib Capsules in multiple strengths EP News Bureau Apr 30, 2025 Approval from USFDA allows Strides Pharma to market Celecoxib Capsules 100 mg, 200 mg, and 400 mg in the United States